grizzly,
don't think you have the forward PE right. All we know is that the H/Y result will comfortably exceed the $2.2 million full year result last year.
So for the sake of the exercise let's say a H/Y result of $4 million is released in the next few weeks. Not even allowing for any further increase in the second half that would be a $8 million net profit for the year, an eps of 8c.
At the present shareprice of $1.50 that's a PE of 18.
Revenue and profits are growing strongly now so let's go one further and assume the first half net profit is $4million and a second half net profit is $6 million, total for the year of $10 million which is a forward PE of 15.
H/Y result will clear away the fog.
regards, EB
- Forums
- ASX - By Stock
- CST
- fin rev.
fin rev., page-3
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CST (ASX) to my watchlist
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online